Purity: Valoración ≥98,0 % en base seca por HPLC (o según la monografía farmacopeica), conforme a la especificación de grado farmacéutico/técnico.
Loss on Drying: Pérdida por secado ≤0,5 % p/p, determinada según el método farmacopeico (USP <731> / Ph. Eur. 2.2.32).
Residual Solvents: Disolventes residuales controlados dentro de los límites ICH Q3C para la clase de disolvente correspondiente.
Perfil de impurezas: Cualquier impureza individual no especificada ≤0,10 %; impurezas totales ≤0,50 %, conforme a la guía ICH Q3A/B.

Otra información

Descripción adicional:

Building on strong chemical development and manufacturing capabilities, Laurus Labs has built an in-house range of APIs and related intermediates, targeting chemistries where it can add real value—pairing innovation with efficiency through cost-effective processes and matching capacity investment for supply reliability. Laurus ranks among the world's leading suppliers of anti-retroviral APIs and intermediates, with low-cost technologies intended to widen medicine access globally. The company partners closely with innovators, global health organizations, and providers to meet cost-reduction goals without compromising quality, and its facilities for handling highly potent materials at development and commercial scale support oncology as a core focus area.